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Galanin N-terminal fragment (1-15) [Gal(1-15)] is involved in mood regulation. We 
have shown that intracerebroventricular (icv) administration of Gal(1-15) produces a 
depressive-like behaviour in the forced swim test (FST) and an anxiety-like behaviour 
in the open field test (OF) in rats. In this work we analyze the effect of Gal(1-15) in two 
more behavioural tests, the tail suspension test (TLT) and the light/dark test. 
 
In light/dark test we studied during 5 min the latency time for entering the dark box, 
time spent in the light compartiment, and the latency time for re-entering the light box 
as parameters indicators of anxiety-like behaviour. In TLT total immobility time was 
analyzed during 6 min test as parameter indicator of depressive-like behaviour. 
 
Groups of rats (n=5-8) were injected icv with Gal(1-15) 3nmol, a dose effective in FST 
and OF, or artificial cerebrospinal fluid 15 minutes before the test. Behavioural 
assessment were conducted with at least one week between tests. Student’s  t-test was 
used for comparation between experimental groups. 
 
In the light/dark test Gal(1-15) 3nmol significantly reduced the time spent in the light 
compartiment by 52% (p<0.05) and the latency time for entering the dark box by 65% 
(p<0.05). An increased in the latency time for re-entering the light box was also 
observed (p<0.05). This pattern of results reflects an anxiogenic-like effects of Gal(1-
15) in this test. 
In the TST, the administration of Gal(1-15) 3nmol significantly increased rat 
immobility by 16% (p<0.05) indicating a depressive-like effect. 
 
These results confirm the depressive- and anxiety-like effects of Gal(1-15) in rats. 
Future therapeutic strategies based on these results could be developed for depression 
and anxiety disorders. 
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